SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Kindred Biosciences, Inc. – ‘DEL AM’ on 1/22/15

On:  Thursday, 1/22/15, at 7:22pm ET   ·   As of:  1/23/15   ·   Effective:  1/23/15   ·   Accession #:  1561743-15-4   ·   File #:  333-201553

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size

 1/23/15  Kindred Biosciences, Inc.         DEL AM      1/23/15    1:9K

Registration Effectiveness-Delaying Amendment
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEL AM      Registration Effectiveness-Delaying Amendment       HTML      7K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  DEL AM 1  




Kindred Biosciences, Inc.
1555 Bayshore Highway, Suite 200
Burlingame, California 94010

January 22, 2015


VIA EDGAR

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
 
    
Re:
Kindred Biosciences, Inc. Registration Statement on Form S-3
 (File No. 333-201553)
Ladies and Gentlemen:
    
Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the cover page of the Registration Statement on Form S-3 (File No. 333-201553) filed by Kindred Biosciences, Inc. on January 16, 2015, following the calculation of the registration fee on such cover page:
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission acting pursuant to said Section 8(a), may determine.”
If you have any questions or comments in connection with this delaying amendment, please contact Marc L. Brown of TroyGould PC at 310-789-1269.

Sincerely,

/s/ Richard Chin, M.D.
Richard Chin, M.D.
President and Chief Executive Officer
Kindred Biosciences, Inc.






Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘DEL AM’ Filing    Date    Other Filings
Filed as of / Effective on:1/23/15
Filed on:1/22/15
1/16/15S-3
 List all Filings 
Top
Filing Submission 0001561743-15-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 8:41:54.1am ET